These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Substituted 3-(phenylmethyl)-1H-indole-5-carboxamides and 1-(phenylmethyl)indole-6-carboxamides as potent, selective, orally active antagonists of the peptidoleukotrienes. Jacobs RT; Brown FJ; Cronk LA; Aharony D; Buckner CK; Kusner EJ; Kirkland KM; Neilson KL J Med Chem; 1993 Feb; 36(3):394-409. PubMed ID: 8381184 [TBL] [Abstract][Full Text] [Related]
7. Non-imidazole histamine H3 ligands. Part I. Synthesis of 2-(1-piperazinyl)- and 2-(hexahydro-1H-1,4-diazepin-1-yl)benzothiazole derivatives as H3-antagonists with H1 blocking activities. Walczyński K; Guryn R; Zuiderveld OP; Timmerman H Farmaco; 1999 Oct; 54(10):684-94. PubMed ID: 10575738 [TBL] [Abstract][Full Text] [Related]
8. Acrylamide derivatives as antiallergic agents. 2. Synthesis and structure-activity relationships of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(3-pyridyl)acryl amides. Nishikawa Y; Shindo T; Ishii K; Nakamura H; Kon T; Uno H J Med Chem; 1989 Mar; 32(3):583-93. PubMed ID: 2465410 [TBL] [Abstract][Full Text] [Related]
9. Evolution of a series of peptidoleukotriene antagonists: synthesis and structure/activity relationships of 1,3,5-substituted indoles and indazoles. Matassa VG; Maduskuie TP; Shapiro HS; Hesp B; Snyder DW; Aharony D; Krell RD; Keith RA J Med Chem; 1990 Jun; 33(6):1781-90. PubMed ID: 2342072 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of N-aryl-3-(indol-3-yl)propanamides and their immunosuppressive activities. Giraud F; Marchand P; Carbonnelle D; Sartor M; Lang F; Duflos M Bioorg Med Chem Lett; 2010 Sep; 20(17):5203-6. PubMed ID: 20655209 [TBL] [Abstract][Full Text] [Related]
11. Quantitative structure-activity relationship study on N-(pyridin-4-yl)-(indol-3-yl) alkylamides as antiallergic agents. Singh P; Sharma BK; Kumar R Indian J Biochem Biophys; 2002 Oct; 39(5):351-5. PubMed ID: 22905382 [TBL] [Abstract][Full Text] [Related]
12. The pharmacology of isamoxole [2-methyl-n-butyl-n(4-methyloxazol-2-yl) propanamide] LRCL 3950, a new anti-allergic compound. Dawson W; Sweatman WJ Br J Pharmacol; 1980; 71(2):387-98. PubMed ID: 6781575 [TBL] [Abstract][Full Text] [Related]
13. Evolution of a series of peptidoleukotriene antagonists: synthesis and structure-activity relationships of 1,6-disubstituted indoles and indazoles. Brown FJ; Yee YK; Cronk LA; Hebbel KC; Krell RD; Snyder DW J Med Chem; 1990 Jun; 33(6):1771-81. PubMed ID: 2342071 [TBL] [Abstract][Full Text] [Related]
14. The anti-allergic activity of Benoxaprofen [2-(4-chlorophenyl)-alpha-methyl-5-benzoxazole acetic acid]--a lipoxygenase inhibitor. Boot JR; Sweatman WJ; Cox BA; Stone K; Dawson W Int Arch Allergy Appl Immunol; 1982; 67(4):340-3. PubMed ID: 6175583 [TBL] [Abstract][Full Text] [Related]
15. New N-(pyridin-4-yl)-(indol-3-yl)acetamides and propanamides as antiallergic agents. Menciu C; Duflos M; Fouchard F; Le Baut G; Emig P; Achterrath U; Szelenyi I; Nickel B; Schmidt J; Kutscher B; Günther E J Med Chem; 1999 Feb; 42(4):638-48. PubMed ID: 10052971 [TBL] [Abstract][Full Text] [Related]
16. New antihistaminic N-heterocyclic 4-piperidinamines. 1. Synthesis and antihistaminic activity of N-(4-piperidinyl)-1H-benzimidazol-2-amines. Janssens F; Torremans J; Janssen M; Stokbroekx RA; Luyckx M; Janssen PA J Med Chem; 1985 Dec; 28(12):1925-33. PubMed ID: 4068010 [TBL] [Abstract][Full Text] [Related]
17. Non-Imidazole Histamine H₃ Ligands. Part VII. Synthesis, In Vitro and In Vivo Characterization of 5-Substituted-2-thiazol-4-n-propylpiperazines. Guryn R; Staszewski M; Stasiak A; McNaught Flores D; Fogel WA; Leurs R; Walczyński K Molecules; 2018 Feb; 23(2):. PubMed ID: 29401659 [TBL] [Abstract][Full Text] [Related]
18. Histamine H1 receptor ligands: part II. Synthesis and in vitro pharmacology of 2-[2-(phenylamino)thiazol-4-yl]ethanamine and 2-(2-benzhydrylthiazol-4-yl)ethanamine derivatives. Walczyński K; Guryn R; Zuiderveld OP; Zhang MQ; Timmerman H Farmaco; 2000; 55(9-10):569-74. PubMed ID: 11152236 [TBL] [Abstract][Full Text] [Related]
19. In vivo anti-allergic and bronchopulmonary pharmacology of REV 3164 in rats and guinea-pigs. Leibowitz M; Gordon RJ; Wolf PS; Sonnino-Goldman P Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):135-54. PubMed ID: 6497506 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiallergy activity of [1,3,4]thiadiazolo[3,2-a]-1,2,3-triazolo[4,5-d]pyrimidin-9(3H)-one derivatives. II. 6-Alkyl- and 6-cycloalkylalkyl derivatives. Yokohama S; Miwa T; Aibara S; Fujiwara H; Matsumoto H; Nakayama K; Iwamoto T; Mori M; Moroi R; Tsukada W Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2391-8. PubMed ID: 1446361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]